Cargando…

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats

Dopamine receptor-D2 (DRD2) is the most important drug target in prolactinoma. The aim of this current study was to investigate the role of using micro-positron emission tomography (micro-PET) with (18)F-fallypride and (18)F-fluorodeoxyglucose ((18)F-FDG) as molecular imaging tracer in the pituitary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, Gui, Songbai, Cao, Lei, Gao, Hua, Bai, Jiwei, Li, Chuzhong, Zhang, Yazhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827909/ https://www.ncbi.nlm.nih.gov/pubmed/27103832 http://dx.doi.org/10.2147/OTT.S94057

Ejemplares similares

(18)F-fallypride and (11)C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series
por: Damian, Andres, et al.
Publicado: (2021)

Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: (18)F-Fallypride Positron Emission Tomography Study
por: Kuepper, Rebecca, et al.
Publicado: (2013)

Multi-GBq production of the radiotracer [(18)F]fallypride in a droplet microreactor
por: Wang, Jia, et al.
Publicado: (2020)

18F-FDG 18F-FDG Positron Emission Tomography Imaging of Cortical Reorganization in Spinal Trauma
por: Chopra, Jigyasa, et al.
Publicado: (2022)

[(18)F]fallypride characterization of striatal and extrastriatal D(2/3) receptors in Parkinson's disease
por: Stark, Adam J., et al.
Publicado: (2018)

Exercise against cocaine sensitization in mice: a [(18)F]fallypride micro-PET study
por: Becker, Guillaume, et al.
Publicado: (2021)

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
por: Gao, Hua, et al.
Publicado: (2015)

Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using (18)F-fallypride micro-positron emission tomography scanning
por: FA, YI-HUA, et al.
Publicado: (2016)

Head-to-head comparison of tau positron emission tomography tracers [(18)F]flortaucipir and [(18)F]RO948
por: Smith, Ruben, et al.
Publicado: (2019)

(18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis
por: Harisankar, C. N. B., et al.
Publicado: (2012)

A Dual Tracer (18)F-FCH/(18)F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model
por: Fu, Yilong, et al.
Publicado: (2016)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

Tracer‐specific reference tissues selection improves detection of (18)F‐FDG, (18)F‐florbetapir, and (18)F‐flortaucipir PET SUVR changes in Alzheimer's disease
por: Li, Yanxiao, et al.
Publicado: (2022)

Pituitary (18)F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on (18)F-FDG PET/CT
por: Ding, Yingli, et al.
Publicado: (2019)

18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review
por: Ghidaglia, Jérôme, et al.
Publicado: (2022)

Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
por: Wu, Albert, et al.
Publicado: (2012)

Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
por: Vogel, Jonas, et al.
Publicado: (2023)

A fingerprint of 2-[(18)F]FDG radiometabolites – How tissue-specific metabolism beyond 2-[(18)F]FDG-6-P could affect tracer accumulation
por: Patronas, Eva-Maria, et al.
Publicado: (2023)

Ultrafast Photoclick Reaction for Selective (18)F-Positron Emission Tomography Tracer Synthesis in Flow
por: Fu, Youxin, et al.
Publicado: (2021)

Identification of a novel somatic mutation of POU6F2 by whole‐genome sequencing in prolactinoma
por: Miao, Yazhou, et al.
Publicado: (2019)

Lower [(18)F]fallypride binding to dopamine D(2/3) receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study
por: van Duin, Esther D. A., et al.
Publicado: (2020)

Differences in in vitro microglial accumulation of the energy metabolism tracers [(18)F]FDG and [(18)F]BCPP-EF during LPS- and IL4 stimulation
por: Suzuki, Chie, et al.
Publicado: (2021)

([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
por: Gallais Sérézal, I., et al.
Publicado: (2021)

Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018)

Toxicogenomic assessment of liver responses following subchronic exposure to furan in Fischer F344 rats
por: Dong, Hongyan, et al.
Publicado: (2015)

Biological Evaluation of [(18)F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma
por: Lin, Liping, et al.
Publicado: (2021)

Inhibitory Effects of Anti-VEGF Antibody on the Growth and Angiogenesis of Estrogen-induced Pituitary Prolactinoma in Fischer 344 Rats: Animal Model of VEGF-targeted Therapy for Human Endocrine Tumors
por: Miyajima, Katsuhiro, et al.
Publicado: (2010)

[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
por: Jensen, Mette Munk, et al.
Publicado: (2013)

Metabolic Pattern of Asymptomatic Hip-Prosthesis by 18F-FDG-Positron-Emission-Tomography
por: Beslic, Nermina, et al.
Publicado: (2015)

Analysis of (18)F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions
por: Seok, Hannah, et al.
Publicado: (2013)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Evaluation of pituitary uptake incidentally identified on (18)F-FDG PET/CT scan
por: Ju, Huijun, et al.
Publicado: (2017)

High Correlation of Static First-Minute-Frame (FMF) PET Imaging after (18)F-Labeled Amyloid Tracer Injection with [(18)F]FDG PET Imaging
por: Seiffert, Alexander P., et al.
Publicado: (2021)

[(18)F]fallypride-PET/CT Analysis of the Dopamine D(2)/D(3) Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection
por: Mann, Teresa, et al.
Publicado: (2018)

Radiosynthesis of the norepinephrine transporter tracer [(18)F]NS12137 via copper‐mediated (18) F‐labelling
por: Lahdenpohja, Salla, et al.
Publicado: (2019)

Nonneoplastic lesions of the ovary in Fischer 344 rats and B6C3F1 mice.
por: Montgomery, C A, et al.
Publicado: (1987)

[(18)F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma
por: Valtorta, Silvia, et al.
Publicado: (2021)

Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol - pituitary tumor induction in Fischer 344 rats
por: Jeng, Yow-Jiun, et al.
Publicado: (2010)

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
por: Kolinger, Guilherme D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ovc7728o2rkhgrefot48vub13i